Market Logic Software and Alchemy-RX Announce Strategic Partnership to Accelerate Transformation of Insights to Growth
BERLIN, DE / ACCESS Newswire / May 13, 2025 / Market Logic Software, the market-leading SaaS provider of insight management solutions, announces a strategic partnership with Alchemy-Rx, a growth consultancy. Together, the two firms will help brands unlock the full value of insights - transforming research and data into topline growth.
This partnership brings together complementary capabilities: Market Logic's AI-powered technology platform DeepSights™ - which centralizes and synthesizes research across knowledge sources - and Alchemy-Rx's proven methods to turning those insights into high-impact ideas. While Market Logic enables organizations to uncover trusted insights faster and more effectively, Alchemy-Rx helps brands act on those insights to fuel incremental revenue.
"DeepSights is best-in-class-when it comes to insight management," said Richard Davies, Co-Founder of Alchemy-Rx. "This partnership combines our strengths. Making sense of multiple data sources to discover an insight is the critical first step in the battle to seize growth opportunities. Knowing how to act on those insights is what secures success and drives impact."
"As we join forces with Alchemy-Rx, we're excited to help customers realise the full value of their knowledge and intelligence," said Olaf Lenzmann, Chief Product and Innovation Officer. "By pairing DeepSights AI capabilities with Alchemy-Rx's expertise, we can help market leading enterprises power their innovation and brand growth strategies with trusted insights."
Market Logic and Alchemy-Rx will also collaborate on future thought leadership, including content and best practices on insight-led innovation and brand growth.
For more information about the partnership, please contact:
Daniela Zuin
CMO
Market Logic Software
Daniela.zuin@marketlogicsoftware.com
Tel: +44 7799 113040
Richard Davies
Co-Founder
Alchemy-Rx
Richard@alchemy-rx.com
Tel: +44 7768 272503
About Market Logic Software:
Market Logic is a market leading SaaS provider of insights management solutions. Our AI-enabled insights management platform, powered by our special purpose AI for Insights technology DeepSights, allows insights teams to equip business decisions makers with trusted insights at scale and speed. Since 2006, we've helped hundreds of consumer-focused brands across the globe to transform into insights-driven businesses. Market leaders such as Unilever, Vodafone, Bayer, and Tesco are driving innovation and making smarter market moves with the support of Market Logic.
Find out more at https://marketlogicsoftware.com/
About Alchemy-Rx
Alchemy-Rx is a growth consultancy designed with one purpose: to help brands grow. We help ambitious brands uncover new opportunities and unlock practical, high-impact strategies. With deep expertise across strategy, marketing, innovation, and analytics, our team brings decades of operating experience to deliver actionable solutions that drive real results. From startups to Fortune 200 companies, clients choose Alchemy-Rx for fast, practical, and effective work tailored to their most pressing growth challenges.
Find out more at https://www.alchemy-rx.com/
SOURCE: Market Logic Software, GmbH
View the original press release on ACCESS Newswire
Market Logic Software, GmbH
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
SafeHeal(R) Receives European Marketing Approval Under MDR for Colovac(R) Anastomosis Protection Technology14.8.2025 22:45:00 CEST | Press release
Marketing approval allows imminent commercialization of the Colovac device in key EU markets PARIS, FRANCE AND TAMPA, FL / ACCESS Newswire / August 14, 2025 / SafeHeal®, a leading innovator in the field of colorectal cancer surgery, today announced that it has been granted European Union marketing approval for its Colovac device under the new Medical Device Regulation (EU MDR 2017/745, Medical Devices, Annex IX Chapter I). This significant milestone confirms the company's compliance with the EU's rigorous safety and performance standards, enabling commercial distribution of Colovac across the European Union. Colovac is intended as an alternative to temporary diverting ostomy for patients undergoing colorectal cancer resection.1,2 "This is a pivotal achievement for our company and a testament to the dedication of our regulatory, clinical, and engineering teams," said Chris Richardson, President and Chief Executive Officer of SafeHeal. "We are now ready to bring the clinical and economic
RAK ICC Strengthens Foundations Regime with 2025 Legislative Enhancements14.8.2025 17:00:00 CEST | Press release
Comprehensive updates improve asset protection, governance, and dispute resolution mechanisms RAS AL KHAIMAH CITY, UAE / ACCESS Newswire / August 14, 2025 / Ras Al Khaimah International Corporate Centre (RAK ICC) has announced significant amendments to its Foundations Regulations 2019, which took effect on 31 July 2025. The changes represent one of the most substantial updates to the regime since its introduction, reinforcing the UAE's position as a competitive jurisdiction for wealth structuring and long-term asset protection. RAK ICC Foundations are widely recognized for their flexibility, confidentiality, and legal robustness, making them a preferred choice for high-net-worth individuals, entrepreneurs, and family offices, both within the UAE and internationally. These structures are commonly used for succession planning, family governance, and consolidating diverse assets under a single legal entity. The 2025 amendments introduce stronger legal safeguards and improved governance me
Picktan Capital's Future Proof Fund Raises $500 Million in Breakout Launch - Fully Subscribed Amid Surging Demand14.8.2025 15:00:00 CEST | Press release
LONDON, UK / ACCESS Newswire / August 14, 2025 / Picktan Capital, a London-headquartered wealth management firm managing over $7 billion in client assets globally, a leader in forward-focused investment strategies, has officially launched its Future Proof Fund, raising $500 million in its initial offering, which is now fully subscribed following an overwhelmingly positive investor response. The Future Proof Fund targets companies driving the next wave of global innovation, with strategic focus areas including: Artificial Intelligence Robotics & Automation Autonomous Systems Fintech & Digital Infrastructure "We built the Future Proof Fund for investors who want more than growth, they want to own the future," said Richard Hart, Head of Private Equity at Picktan Capital. "The fact that we raised $500 million and reached full subscription so quickly is a testament to how strong the demand is for exposure to the sectors that will define the next decade." Due to the strength of demand, Pickt
Loar Holdings Inc. Reports Q2 2025 Record Results and Upward Revision to 2025 Outlook and Announces the Acquisition of Beadlight Ltd.13.8.2025 14:30:00 CEST | Press release
WHITE PLAINS, NY / ACCESS Newswire / August 13, 2025 / Loar Holdings Inc. (NYSE:LOAR) (the "Company," "Loar," "we," "us" and "our"), reports record results for the second quarter of 2025, upward revision to 2025 guidance, and announces the acquisition of Beadlight Ltd. ("Beadlight"). "Strong execution of our value drivers, combined with the rich proprietary content of our diversified portfolio of capabilities aligned perfectly to achieve these record results in the second quarter," stated Dirkson Charles, Loar CEO and Executive Co-Chairman of the Board of Directors. "Each of our end markets experienced record sales, with Commercial OEM being up 18%, Commercial Aftermarket up 29%, and Defense growing 51% as compared to the second quarter of 2024. In addition, I am excited to welcome the team at Beadlight Ltd. to Loar. Beadlight is our 18th completed acquisition since inception in 2012." Second Quarter 2025 Net sales of $123.1 million, up 26.9% compared to the prior year's quarter. Net i
Kalorama Group Named to Inc. 5000 List of America's Fastest-Growing Private Companies12.8.2025 19:35:00 CEST | Press release
Ranked in Top 100 with a 3-Year Growth Rate of nearly 4,400% WASHINGTON, DC / ACCESS Newswire / August 12, 2025 / Kalorama Group, a leading facilitator of transactions between buyers and sellers of IPv4 address blocks, announced today that it has been named to the 2025 Inc. 5000 list of the fastest-growing private companies in America. Kalorama Group came in at number 70 nationwide, number three in the D.C.-Maryland-Virginia metro area, and was ranked the fastest-growing business in the District of Columbia thanks to its extraordinary revenue growth of 4,361% between 2021 and 2024. "This milestone is a testament to our team's deep market expertise and our clients' trust in our ability to navigate a highly specialized asset class," said Josh Bourne, Founder of Kalorama Group. "We've built a reputation for transparency, execution speed, and regulatory insight -- qualities that matter deeply to organizations seeking reliable counsel in the dynamic yet opaque market for IPv4 addresses." Ka
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom